These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 32878787

  • 1. Ephemeranthol A Suppresses Epithelial to Mesenchymal Transition and FAK-Akt Signaling in Lung Cancer Cells.
    Nonpanya N, Prakhongcheep O, Petsri K, Jitjaicham C, Tungsukruthai S, Sritularak B, Chanvorachote P.
    Anticancer Res; 2020 Sep; 40(9):4989-4999. PubMed ID: 32878787
    [Abstract] [Full Text] [Related]

  • 2. Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3.
    Petpiroon N, Sritularak B, Chanvorachote P.
    BMC Complement Altern Med; 2017 Dec 29; 17(1):553. PubMed ID: 29284478
    [Abstract] [Full Text] [Related]

  • 3. Batatasin III Inhibits Migration of Human Lung Cancer Cells by Suppressing Epithelial to Mesenchymal Transition and FAK-AKT Signals.
    Pinkhien T, Petpiroon N, Sritularak B, Chanvorachote P.
    Anticancer Res; 2017 Nov 29; 37(11):6281-6289. PubMed ID: 29061811
    [Abstract] [Full Text] [Related]

  • 4. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition.
    Sanookpan K, Nonpanya N, Sritularak B, Chanvorachote P.
    Molecules; 2021 Jan 26; 26(3):. PubMed ID: 33530617
    [Abstract] [Full Text] [Related]

  • 5. A Bibenzyl from Dendrobium ellipsophyllum inhibits epithelial-to-mesenchymal transition and sensitizes lung cancer cells to anoikis.
    Chaotham C, Pongrakhananon V, Sritularak B, Chanvorachote P.
    Anticancer Res; 2014 Apr 26; 34(4):1931-8. PubMed ID: 24692728
    [Abstract] [Full Text] [Related]

  • 6. Norcycloartocarpin targets Akt and suppresses Akt-dependent survival and epithelial-mesenchymal transition in lung cancer cells.
    Nonpanya N, Sanookpan K, Joyjamras K, Wichadakul D, Sritularak B, Chaotham C, Chanvorachote P.
    PLoS One; 2021 Apr 26; 16(8):e0254929. PubMed ID: 34383763
    [Abstract] [Full Text] [Related]

  • 7. Cycloartobiloxanthone Inhibits Migration and Invasion of Lung Cancer Cells.
    Tungsukruthai S, Sritularak B, Chanvorachote P.
    Anticancer Res; 2017 Nov 26; 37(11):6311-6319. PubMed ID: 29061814
    [Abstract] [Full Text] [Related]

  • 8. The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells.
    Unahabhokha T, Chanvorachote P, Pongrakhananon V.
    Tumour Biol; 2016 Jul 26; 37(7):8633-41. PubMed ID: 26733180
    [Abstract] [Full Text] [Related]

  • 9. Cypripedin diminishes an epithelial-to-mesenchymal transition in non-small cell lung cancer cells through suppression of Akt/GSK-3β signalling.
    Treesuwan S, Sritularak B, Chanvorachote P, Pongrakhananon V.
    Sci Rep; 2018 May 22; 8(1):8009. PubMed ID: 29789636
    [Abstract] [Full Text] [Related]

  • 10. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways.
    Zhou J, Luo J, Gan R, Zhi L, Zhou H, Lv M, Huang Y, Liang G.
    Recent Pat Anticancer Drug Discov; 2024 May 22; 19(4):543-555. PubMed ID: 38305308
    [Abstract] [Full Text] [Related]

  • 11. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis.
    Petpiroon N, Bhummaphan N, Tungsukruthai S, Pinkhien T, Maiuthed A, Sritularak B, Chanvorachote P.
    Phytomedicine; 2019 May 22; 58():152888. PubMed ID: 30901662
    [Abstract] [Full Text] [Related]

  • 12. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway.
    Lee JH, Chinnathambi A, Alharbi SA, Shair OHM, Sethi G, Ahn KS.
    Pharmacol Res; 2019 Dec 22; 150():104504. PubMed ID: 31678208
    [Abstract] [Full Text] [Related]

  • 13. COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner.
    Jiang GB, Fang HY, Tao DY, Chen XP, Cao FL.
    Eur Rev Med Pharmacol Sci; 2019 May 22; 23(9):3838-3846. PubMed ID: 31115011
    [Abstract] [Full Text] [Related]

  • 14. DS-1 Inhibits Migration and Invasion of Non-small-cell Lung Cancer Cells Through Suppression of Epithelial to Mesenchymal Transition and Integrin β1/FAK Signaling.
    Putri HE, Sritularak B, Chanvorachote P.
    Anticancer Res; 2021 Jun 22; 41(6):2913-2923. PubMed ID: 34083282
    [Abstract] [Full Text] [Related]

  • 15. Pongamol Inhibits Epithelial to Mesenchymal Transition Through Suppression of FAK/Akt-mTOR Signaling.
    Putri HE, Sritularak B, Chanvorachote P.
    Anticancer Res; 2021 Dec 22; 41(12):6147-6154. PubMed ID: 34848469
    [Abstract] [Full Text] [Related]

  • 16. Cycloartocarpin Inhibits Migration through the Suppression of Epithelial-to-Mesenchymal Transition and FAK/AKT Signaling in Non-Small-Cell Lung Cancer Cells.
    Tungsukruthai S, Sritularak B, Chanvorachote P.
    Molecules; 2022 Nov 22; 27(23):. PubMed ID: 36500213
    [Abstract] [Full Text] [Related]

  • 17. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells.
    Luo W, Liu Q, Jiang N, Li M, Shi L.
    Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31467176
    [Abstract] [Full Text] [Related]

  • 18. Structure Identification of ViceninII Extracted from Dendrobium officinale and the Reversal of TGF-β1-Induced Epithelial⁻Mesenchymal Transition in Lung Adenocarcinoma Cells through TGF-β/Smad and PI3K/Akt/mTOR Signaling Pathways.
    Luo Y, Ren Z, Du B, Xing S, Huang S, Li Y, Lei Z, Li D, Chen H, Huang Y, Wei G.
    Molecules; 2019 Jan 02; 24(1):. PubMed ID: 30609689
    [Abstract] [Full Text] [Related]

  • 19. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
    Chowdhury P, Dey P, Ghosh S, Sarma A, Ghosh U.
    BMC Cancer; 2019 Aug 22; 19(1):829. PubMed ID: 31438892
    [Abstract] [Full Text] [Related]

  • 20. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR, Han SY, Li XH, Zheng WX, Pang LN, Jiang ST, Li PP.
    J Ethnopharmacol; 2017 May 23; 204():45-57. PubMed ID: 28412214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.